CJC-1295 and Ipamorelin are frequently paired in research due to their complementary mechanisms of action within the growth hormone (GH) axis. Together, they provide a coordinated approach to stimulating endogenous GH release through both hypothalamic and pituitary signaling pathways.

CJC-1295, a growth hormone releasing hormone (GHRH) analog, works by promoting sustained stimulation of GH release, while Ipamorelin, a selective growth hormone secretagogue, triggers pulsatile GH secretion through ghrelin receptor activation. The combination allows researchers to investigate both sustained and episodic GH signaling within a single model.

This dual-pathway approach makes the blend a widely used option in studies focused on recovery signaling, endocrine balance, and the relationship between growth hormone activity and metabolic processes.

Mechanism of Action
This combination targets two complementary pathways:

CJC-1295 (GHRH analog)Stimulates the pituitary to increase growth hormone output over an extended duration

Ipamorelin (Ghrelin receptor agonist)Promotes pulsatile growth hormone release via selective receptor activation

Together, these mechanisms enable a more complete model for studying growth hormone dynamics and downstream signaling effects.

Key Research Applications

• Growth hormone axis stimulation and modeling
• Recovery and repair pathway research
• Endocrine system regulation studies
• Sleep and circadian hormone rhythm research
• Body composition and metabolic signaling

Product Specifications

• Total Quantity: 10mg (combined blend)
• Form: Lyophilized powder
• Purity: ≥99% (HPLC tested)
• Appearance: White to off-white powder

Storage:

• Long-term: -20°C
• Short-term (reconstituted): 2–8°C

Reconstitution Guidance (General Laboratory Use)

• This product is supplied in lyophilized form and requires reconstitution prior to use.
• Use sterile bacteriostatic water
• Introduce solution slowly along the vial wall
• Gently swirl—do not shake
• Final concentration and protocol should be adjusted based on specific research requirements.

Quality Assurance

• Third-party tested for purity and identity
• Batch-specific Certificate of Analysis (COA) available
• Produced by qualified manufacturing partners in controlled laboratory environments

What’s Included

• 1 × 10mg CJC-1295 + Ipamorelin blend vial
• COA access for batch verification

Research Use Notice
For research use only. Not intended for human consumption.